Skip to main content
. 2021 Jan 11;8(1):1869408. doi: 10.1080/20018525.2020.1869408

Table 3.

Adverse events during AD and ATAD

DuringAD n %
URS 7 10%
LRS 18 27%
Dyspepsia 13 19%
Urticaria 5 7%
During ATAD  
URS 4 7%
LRS 5 8%
Dyspepsia 5 8%
Bruises, hemorrhage 2 3%
Urticaria 2 3%
Tinnitus 1 2%

LRS: lower respiratory symptoms, URS: upper respiratory symptoms, AD: ASA desensitization, ATAD: ASA treatment after desensitization, ASA: acetylsalicylic acid.